Search

Author/Creator Voss, M.H.

1. 2622 A Phase I/II study to assess the safety and efficacy of pazopanib (paz) and pembrolizumab (pembro) in patients (pts) with advanced renal cell carcinoma (aRCC). (September 2015)

Authors:
McDermott, D.F.; Infante, J.R.; Chowdhury, S.; Voss, M.H.; Motzer, R.J.; Perini, R.F.; Morosky, A.; Zheng, F.F.; White, B.C.; Wang, Q.; Jewell, R.C.; Rini, B.I.
Journal:
European journal of cancer
Issue:
Volume 51:(2015)Supplement 3
Page Start:
S519
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Outcomes of patients with metastatic clear-cell renal cell carcinoma treated with second-line VEGFR-TKI after first-line immune checkpoint inhibitors. (June 2019)

Authors:
Shah, A.Y.; Kotecha, R.R.; Lemke, E.A.; Chandramohan, A.; Chaim, J.L.; Msaouel, P.; Xiao, L.; Gao, J.; Campbell, M.T.; Zurita, A.J.; Wang, J.; Corn, P.G.; Jonasch, E.; Motzer, R.J.; Sharma, P.; Voss, M.H.; Tannir, N.M.
Journal:
European journal of cancer
Issue:
Volume 114(2019)
Page Start:
67
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search